- Home
- PETS vs RENB Comparison
PETS vs RENB Comparison
Compare PETS & RENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PETS
- RENB
- Stock Information
- Founded
- PETS 1996
- RENB 2011
- Country
- PETS United States
- RENB United States
- Employees
- PETS N/A
- RENB N/A
- Industry
- PETS Retail-Drug Stores and Proprietary Stores
- RENB Biotechnology: Pharmaceutical Preparations
- Sector
- PETS Consumer Staples
- RENB Health Care
- Exchange
- PETS Nasdaq
- RENB Nasdaq
- Market Cap
- PETS 68.6M
- RENB 62.0M
- IPO Year
- PETS N/A
- RENB N/A
- Fundamental
- Price
- PETS $3.32
- RENB $0.27
- Analyst Decision
- PETS Sell
- RENB
- Analyst Count
- PETS 2
- RENB 0
- Target Price
- PETS $3.35
- RENB N/A
- AVG Volume (30 Days)
- PETS 127.9K
- RENB 2.2M
- Earning Date
- PETS 08-05-2025
- RENB 05-15-2025
- Dividend Yield
- PETS N/A
- RENB N/A
- EPS Growth
- PETS N/A
- RENB N/A
- EPS
- PETS 0.02
- RENB N/A
- Revenue
- PETS $247,010,000.00
- RENB N/A
- Revenue This Year
- PETS N/A
- RENB N/A
- Revenue Next Year
- PETS N/A
- RENB N/A
- P/E Ratio
- PETS $194.56
- RENB N/A
- Revenue Growth
- PETS N/A
- RENB N/A
- 52 Week Low
- PETS $2.90
- RENB $0.26
- 52 Week High
- PETS $6.85
- RENB $2.10
- Technical
- Relative Strength Index (RSI)
- PETS 42.37
- RENB 38.03
- Support Level
- PETS $3.32
- RENB $0.33
- Resistance Level
- PETS $3.49
- RENB $0.32
- Average True Range (ATR)
- PETS 0.15
- RENB 0.03
- MACD
- PETS 0.01
- RENB -0.00
- Stochastic Oscillator
- PETS 51.35
- RENB 4.84
About PETS PetMed Express Inc.
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.
About RENB Renovaro Biosciences Inc.
Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.